Fig. 4From: Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinomaKaplan-Meier survival analysis [disease-free interval (DFI) in the upper panel and overall survival (OS) in the lower panel] of 88 lung adenocarcinoma patients stratified according to miR-33a and PD-1 co-expression. Patients with high miR-33a/lowPD-1 tumors had better survival rates than patients with low miR-33a/lowPD-1 tumorsBack to article page